fig8
From: EGFR signaling promotes resistance to CHK1 inhibitor prexasertib in triple negative breast cancer
Figure 8. Immunoblotting of MDA-468 xenografts. MDA-468 xenograft tumors were excised and examined for the indicated protein expression. Three tumors per group were analyzed. AKT: protein kinase B; EGFR: epidermal growth factor receptor
